Hapten-protein binding:: from theory to practical application in the in vitro prediction of skin sensitization

被引:163
作者
Divkovic, M [1 ]
Pease, CK
Gerberick, GF
Basketter, DA
机构
[1] Unilever Colworth, Safety & Environm Assurance Ctr, Colworth House, Sharnbrook MK44 1LQ, Beds, England
[2] Procter & Gamble Co, Cincinnati, OH USA
关键词
hapten-protein binding; in vitro assay; peptide binding; skin sensitization;
D O I
10.1111/j.0105-1873.2005.00683.x
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
In view of the forthcoming European Union ban on in vivo testing of cosmetic and toiletry ingredients, following the publication of the 7th amendment to the Cosmetics Directive, the search for practical, alternative, non-animal approaches is gathering pace. For the end-point of skin sensitization, the ultimate goal, i.e. the development and validation of alternative in vitro/in silico assays by 2013, may be achieved through a better understanding of the skin sensitization process on the cellular and molecular levels. One of the key molecular events in skin sensitization is protein haptenation, i.e. the chemical modification of self-skin protein(s) thus forming macromolecular immunogens. This concept is widely accepted and in theory can be used to explain the sensitizing capacity of many known skin sensitizers. Thus, the principle of protein or peptide haptenation could be used in in vitro assays to predict the sensitization potential of a new chemical entity. In this review, we consider some of the theoretical aspects of protein haptenation, how mechanisms of protein haptenation can be investigated experimentally and how we can use such knowledge in the development of novel, alternative approaches for predicting skin sensitization potential in the future.
引用
收藏
页码:189 / 200
页数:12
相关论文
共 68 条
[1]   Reactivity of contact allergenic haptens to amino acid residues in a model carrier peptide, and characterization of formed peptide-hapten adducts [J].
Ahlfors, SR ;
Sterner, O ;
Hansson, C .
SKIN PHARMACOLOGY AND APPLIED SKIN PHYSIOLOGY, 2003, 16 (01) :59-68
[2]   Peptide mapping identifies hotspot site of modification in human serum albumin by methylglyoxal involved in ligand binding and esterase activity [J].
Ahmed, N ;
Dobler, D ;
Dean, M ;
Thornalley, PJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (07) :5724-5732
[3]   p38 mitogen-activated protein kinase and extracellular signal-regulated kinases play distinct roles in the activation of dendritic cells by two representative haptens, NiCl2 and 2,4-dinitrochlorobenzene [J].
Aiba, S ;
Manome, H ;
Nakagawa, S ;
Mollah, ZUA ;
Mizuashi, M ;
Ohtani, T ;
Yoshino, Y ;
Tagami, H .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2003, 120 (03) :390-399
[4]   Effect of glutathione on the covalent binding of the 13C-labeled skin sensitizer 5-chloro-2-methylisothiazol-3-one to human serum albumin:: Identification of adducts by nuclear magnetlic resonance, matrix-assisted laser desorption/ionization mass spectrometry, and nanoelectrospray tandem mass spectrometry [J].
Alvarez-Sánchez, R ;
Divkovic, M ;
Basketter, D ;
Pease, C ;
Panico, M ;
Dell, A ;
Morris, H ;
Lepoittevin, JP .
CHEMICAL RESEARCH IN TOXICOLOGY, 2004, 17 (09) :1280-1288
[5]   Covalent binding of the 13C-labeled skin sensitizers 5-chloro-2-methylisothiazol-3-one (MCI) and 2-methylisothiazol-3-one (MI) to a model peptide and glutathione [J].
Alvarez-Sánchez, R ;
Basketter, D ;
Pease, C ;
Lepoittevin, JP .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (02) :365-368
[6]   Studies of chemical selectivity of hapten, reactivity, and skin sensitization potency.: 3.: Synthesis and studies on the reactivity toward model nucleophiles of the 13C-Labeled skin sensitizers, 5-chloro-2-methylisothiazol-3-one (MCI) and 2-methylisothiazol-3-one (MI) [J].
Alvarez-Sánchez, R ;
Basketter, D ;
Pease, C ;
Lepoittevin, JP .
CHEMICAL RESEARCH IN TOXICOLOGY, 2003, 16 (05) :627-636
[7]   Reaction of N-acetylglycyllysine methyl ester with 2-alkenals:: An alternative model for covalent modification of proteins [J].
Baker, A ;
Zídek, L ;
Wiesler, D ;
Chmelík, J ;
Pagel, M ;
Novotny, MV .
CHEMICAL RESEARCH IN TOXICOLOGY, 1998, 11 (07) :730-740
[8]   Drug metabolism in the skin [J].
Baron, Jens M. ;
Merk, Hans F. .
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 1 (04) :287-291
[9]   THE CHEMISTRY OF CONTACT ALLERGY - WHY IS A MOLECULE ALLERGENIC [J].
BASKETTER, D ;
DOOMSGOOSSENS, A ;
KARLBERG, AT ;
LEPOITTEVIN, JP .
CONTACT DERMATITIS, 1995, 32 (02) :65-73
[10]   Skin sensitization risk assessment: a comparative evaluation of 3 isothiazolinone biocides [J].
Basketter, DA ;
Rodford, R ;
Kimber, I ;
Smith, I ;
Wahlberg, JE .
CONTACT DERMATITIS, 1999, 40 (03) :150-154